BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 15, 2025
See today's BioWorld MedTech
Home
» Chinese med-tech firm seeks to win in China, then disrupt U.S. market
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Chinese med-tech firm seeks to win in China, then disrupt U.S. market
March 20, 2013
By
Larry Schuster
No Comments
SHANGHAI – In China, local med-tech manufacturers have successfully pushed multinationals' products to the side at least in some product lines, due to strong government incentives, their low cost and improved quality.
BioWorld MedTech